After the first reporting of the index case of Severe Acute Respiratory Syndrome (SARS)-CoV-
2-associated disease at the end of December 2019, the virus spread quickly throughout the …

Background We estimated COVID-19 vaccine effectiveness against SARS-CoV-2 infection
and severe COVID-19 outcomes among individuals with immune-mediated inflammatory …

COVID-19 is a recently emerged viral infection worldwide. SARS-CoV-2, the causative virus,
is believed to have emerged from bat coronaviruses, probably through host conversion. The …

Background In the context of immune-mediated inflammatory diseases (IMIDs), COVID-19
outcomes are incompletely understood and vary considerably depending on the patient …

Background COVID-19 outcomes, in the context of immune-mediated inflammatory diseases
(IMIDs), are incompletely understood. Reported outcomes vary considerably depending on …

Introduction: The COVID-19 pandemic is a result of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). Vaccination against COVID-19 is crucial for preventing severe …

Objective In the face of the ongoing circulation of SARS‐CoV‐2, the durability of
neutralization post–COVID‐19 vaccination in immune‐mediated inflammatory disease …

Introduction Recent evidence shows that COVID-19 infection does not have a worse
prognosis in patients with immune-mediated inflammatory diseases (IMID), although they …

Zusammenfassung Die Pandemie durch die Coronavirus Disease 2019 (COVID-19)
beeinflusst weiter das Leben von Patient* innen mit chronisch-entzündlichen …

People with multiple sclerosis (PWMS) are at high risk of being affected by the disruption of
health services that occurred during the COVID-19 pandemic months. The aim of this study …